Following the resignation of its Managing Director, Dayanand Thandalam Sriram, GlaxoSmithKline Consumer Nigeria Plc, GSK, has announced the appointment of Bhushan Akshikar as the new Managing Director. This takes effect from 20 March 2018.
The Former Managing Director, Dayanand Thandalam Sriram took over at GSK Consumer four years ago.
During his period as the Managing Director, he oversaw the successful divestment of the company ‘s drinks business and led the restructuring of the business. which includes
- Tightening up of the brand portfolio.
- Refocusing of investment on power brands.
- Initiatives for driving operational efficiency.
- Investment in building talents and capabilities to drive growth in the company’s Consumer business.
The new Managing Director also comes with a wealth of experience. He joined GSK in 2011 as Vice President GSK Pharmaceuticals India.
Prior to joining the company, he spent 16years with Johnson & Johnson in positions of increasing responsibilities in diverse markets like India, Belgium, and South Korea.
While in India as the Executive Vice President, he led the Mass and Specialty Business Units to deliver £150 million in annual sales revenue.
In January 2017, Akshikar was appointed General Manager GlaxoSmithKline Pharmaceutical Nigeria Limited and was appointed as a Non-executive Director on the Board in March 2017.
GlaxoSmithKline Consumer Nigeria Plc is a subsidiary of GSK group and involved in the manufacturing, marketing, and distribution of healthcare products in the country. The Company also sells Ribena fruit juices and Lucozade energy drinks. The Company was listed on Nigerian Stock Exchange in July 1979.
